Macquarie Reaffirms Outperform Rating for Addus HomeCare (NASDAQ:ADUS)

Macquarie reaffirmed their outperform rating on shares of Addus HomeCare (NASDAQ:ADUS) in a research report report published on Thursday morning,Benzinga reports. Macquarie currently has a $129.00 price objective on the stock.

Several other analysts also recently weighed in on the company. Oppenheimer lifted their price objective on Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a report on Friday, January 24th. JMP Securities started coverage on Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price on the stock. StockNews.com lowered Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday. Royal Bank of Canada reiterated an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research note on Thursday, November 14th. Finally, Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, Addus HomeCare has an average rating of “Moderate Buy” and a consensus target price of $132.78.

Addus HomeCare Price Performance

ADUS stock opened at $96.86 on Thursday. The business has a 50-day moving average price of $122.60 and a 200 day moving average price of $126.08. The company has a market capitalization of $1.76 billion, a P/E ratio of 22.16, a PEG ratio of 1.41 and a beta of 1.00. Addus HomeCare has a 1-year low of $87.88 and a 1-year high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.35 by ($0.09). The firm had revenue of $297.14 million during the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. On average, analysts anticipate that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Transactions at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares of the company’s stock, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. This trade represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Institutional investors and hedge funds have recently modified their holdings of the company. Quarry LP acquired a new stake in shares of Addus HomeCare during the third quarter worth about $28,000. Natixis lifted its holdings in shares of Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company’s stock worth $31,000 after purchasing an additional 132 shares during the period. Smartleaf Asset Management LLC lifted its holdings in shares of Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock worth $35,000 after purchasing an additional 214 shares during the period. Farther Finance Advisors LLC lifted its holdings in Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after acquiring an additional 366 shares during the period. Finally, Parkside Financial Bank & Trust lifted its holdings in Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock valued at $67,000 after acquiring an additional 148 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.